Financing Fertility Treatment

11/11/2008 News For:

Financing Fertility Treatment

Freezing Ovaries Preserves Fertility, Scientists Report   MONDAY, Nov. 10 HealthDay News -- Scientists are reporting the ability to freeze and transplant ovaries, a development that could help preserve fertility in women facing cancer therapy.

NY-Presbyterian Hospital/Columbia University Medical Center Fertility Experts Present The Latest Research At ...  Leading fertility experts at NewYork-Presbyterian Hospital/Columbia University Medical Center are presenting new research findings at the 64th annual American Society of Reproductive Medicine ASRM meeting in San Francisco, Nov. 8-12. Highlights include the following: - Dr. Mark V. Sauer is chairing the invited symposia, "Management of the HIV-Discordant Couple Seeking Fertility Care.

TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer  GenVec, Inc. Nasdaq:GNVC announced today that TNFeradeTM has been granted Fast Track product designation by the U.S. Food and Drug Administration FDA for its proposed use in the treatment of locally advanced pancreatic cancer. The designation is based on GenVec having "provided evidence of the potential to improve survival in patients with pancreatic cancer."

Freezing Ovaries Preserves Fertility, Scientists Report  New technique could help cancer patients or women who want to delay childbirth.

Hopkins cancer specialist focuses on preventative side of treatment  Dr. Khalid Mahmud sees cancer treatment as two sides of a coin. One includes the medicines and procedures patients undergo after diagnosis. Mahmud worked on that spectrum of medicine for 25 years as a cancer and internal-medicine specialist.

TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer   GAITHERSBURG, Md.----GenVec, Inc. announced today that TNFerade? has been granted Fast Track product designation by the U.S. Food and Drug Administration for its proposed use in the treatment of locally advanced pancreatic cancer.

Trial of investigational drug for treatment of advanced heart failure  UC San Diego Medical Center is currently enrolling patients in a Phase 2 clinical trial of an investigational drug for the treatment of advanced heart failure.

Safeguard Scientifics co-leads financing of Molecular Biometrics  Safeguard Scientifics Inc. said Monday it has co-led a $12 million, first-round venture-capital financing of Molecular Biometrics Inc. of Chester, N.J. Oxford Bioscience Partners of Boston was the other co-leader. SFE

Bone cancer treatment ineffective, despite promising laboratory data  Ewing sarcoma is the second most common type of primary bone cancer seen in children and young adults. Patients with relapsed or refractory Ewing sarcoma have a poor outcome with conventional therapies. Cytarabine decreases the levels of a certain key protein in Ewing sarcoma cells and has demonstrated preclinical activity against Ewing sarcoma cell lines in the laboratory. Treatment of Ewing ...

Eight Years' Experience With High-Intensity Focused Ultrasonography For Treatment Of Localized Prostate Cancer  BERKELEY, CA UroToday.com - High-intensity focused ultrasonography HIFU is an approach to the treatment of prostate cancer CaP. While not FDA approved in the US, it is approved and gaining popularity in many countries. HIFU utilizes acoustic energy delivered from a transducer, resulting in tissue destruction in the path of the ultrasound beam.

Financing Fertility Treatment

Instant Health Insurance Quote Short Form:

Financing Fertility Treatment